Posts in tag

kidney health


Debbie Rigby rounds up the latest in research news  Relationship of inhaled long-acting bronchodilators with cardiovascular outcomes among patients with stable COPD A meta-analysis and systematic review of 43 randomized …

Debbie Rigby takes a look at the latest in research news Prescribing of diabetes medications to people with type 2 diabetes and chronic kidney disease Analysis of Australia GP prescribing …

Debbie Rigby rounds up the latest in research news Atrial Fibrillation and Chronic Kidney Disease Analysis of registry data in GARFIELD‐AF shows moderate‐to‐severe CKD was independently associated with stroke/systemic embolism, …

PDL has highlighted the importance of taking patient concerns and questions seriously, after a dispensing error contributed to a patient’s death In a recent coronial inquest, it was found that …

Debbie Rigby rounds up the latest in research news  Developing a measure of polypharmacy appropriateness in primary care A systematic review and expert consensus study has identified 12 implicit indicators …

Debbie Rigby takes a look at the latest in research news Changes in Prescribing Symptomatic and Preventive Medications in the Last Year of Life in Older Nursing Home Residents A …

Nearly three-quarters of pharmacists would like to see greater restrictions on the availability of ibuprofen, an AJP poll has revealed Following concerns expressed by pharmacists that Australians could be at …

A pharmacist believed the dose of methotrexate prescribed to a man who later died was inappropriate – but her concerns were ignored Fairfax media outlets have reported on the inquest …

Amcal’s Kidney Health Assessment program has been awarded the title of Best Public Health Initiative The award was presented at the annual Prime Awards at a ceremony in Sydney. The …

Debbie Rigby takes a look at the latest research news Is pyridoxine effective and safe for post-partum lactation inhibition? A systematic review of 7 randomised controlled trials has shown inconsistent …

A relatively new drug has been found to greatly reduce risk of cardiovascular and kidney disease – though it comes with risks of its own Canagliflozin (Invokana) is a SGLT2 …

Most Australians have no idea about the risks of chronic kidney disease and some don’t know how many kidneys we have, Amcal data has found That’s despite one in three …